Clinical management of pregnant women with the risk of pre-eclampsia developing

Hypertensive disorders in pregnancy remain important problem of modern obstetrics, their frequency being 2-8% with no tendency of decreasing. To identify pregnant women with high risk and to conduct preventive treatment is very important for the practitioner. The aim of the study was to develop and...

Full description

Bibliographic Details
Main Author: Loskutova T.O.
Format: electronic Article
Language:English
Russian
Ukrainian
Physical Description:Online-Ressource
QR Code: Show QR Code
LEADER 02707nma a2200265 c 4500
001 DOAJ017235987
003 DE-601
005 20191108072947.0
007 cr uuu---uuuuu
008 171226s2015 000 0 eng d
035 |a (DE-599)DOAJ7c1e247d5565492a95696c6f7a6ba4ab 
040 |b ger  |c GBVCP 
041 0 |a eng  |a rus  |a ukr 
100 0 |a Loskutova T.O. 
245 1 0 |a Clinical management of pregnant women with the risk of pre-eclampsia developing  |h Elektronische Ressource 
300 |a Online-Ressource 
520 |a Hypertensive disorders in pregnancy remain important problem of modern obstetrics, their frequency being 2-8% with no tendency of decreasing. To identify pregnant women with high risk and to conduct preventive treatment is very important for the practitioner. The aim of the study was to develop and justify differential management of pregnants depending on the risk of preeclampsia. 131 pregnant women in I trimester were tested to determine the risk of hypertensive disorders. Prediction model allows to identify pregnant women with risk of hypertensive disorders according to the results of testing thrombophilia genes (presence of 455G → A polymorphism in the gene for fibrinogen β and 4G/5G in gene of plasminogen activator inhibitor - type 1), the level of antibodies to β2 glycoprotein-1, the level of D-dimer and the value of atherogenicity coefficient. Pregnant women with high risk of hypertensive disorders, received prophylactic treatment complex. This complex included antiplatelet therapy, correction of hyperho¬mo¬cysteinemia and hypercholesterolemia levels. Etio-pathogenic concept of prediction and prevention of pre-eclampsia associated with thrombophilia was proposed. The proposed scheme of preventive treatment allowed to normalize blood clotting parameters, lipid metabolism, to reduce the number of thrombophilia markers. The necessity of early and long-term administration of prophylactic complex was proved. This management prevents endothelial damage and deve¬lopment of pathological range of pre-eclampsia. The results of prophylactic treatment were the reduction of preeclampsia cases by 6,5 times (p < 0.05), number of complicated deliveries by 3 times (p <0.05), number of preterm birth by 6,57 times (p <0.05), cases of growth retardation by 9,8 times (p = 0.003), increase of newborns’ weight by 1,24 times (p = 0.02). 
773 0 8 |i In  |g  (01.03.2015) 
856 4 0 |y DOAJ  |u https://doaj.org/article/7c1e247d5565492a95696c6f7a6ba4ab 
856 4 0 |u http://medpers.dsma.dp.ua/issues/2015/N1/62-69.pdf 
856 4 0 |u https://doaj.org/toc/2307-0404 
856 4 0 |u https://doaj.org/toc/2307-0404 
912 |a GBV_DOAJ 
951 |a AR 
952 |j 2015  |b 01  |c 03